1. Field of Invention
This invention relates to ocular devices such as intraocular lenses wherein the lens is an anterior chamber, iris slip, or posterior chamber intraocular lens. Currently, commercially available intraocular lenses provide increased absorbance of UV light from unfiltered light sources with UV absorbing substrates in the polymer blend of the lens. Blue light blocking technology also exists in the market place to improve the vision of patients with intraocular lenses implants. Patients with implanted intraocular lenses often see what is known as edge glare. Edge glare refers to light rays that focus on the retina and create high contrast in the vision of images seen by the patient. Lens edge glare generally falls into the categories of discomfort glare and disability glare. Discomfort glare encourages a patient to look away from an image or environment to avoid glare to avoid discomfort whereas disability glare inhibits visibility with bright light sources.
2. Description of Prior Art
To reduce edge glare, various edge designs have been discovered and implemented in the intraocular lens implant market. In particular, edge designs include frosting, rounding, and sharpening of the edge of the lens.
The edge design selected must also eliminate or decrease the amount of posterior capsule opacification (PCO) that requires some intraocular lens implant patients to have additional surgery. PCO, sometimes called “secondary cataract,” is the most common long-term complication of modern cataract surgery. The problem develops when the posterior portion of the capsular bag—the structure which encloses the eye's natural lense—begins to get cloudy. The posterior portion of this bag is left intact during cataract surgery to prevent leakage of vitreous from behind the capsule, which could cause a detached retina. PCO can occur months or years after cataract surgery, unlike most other cataract surgery complications that then to occur during or shortly after the procedure.
Within 2 to 5 years after surgery, PCO causes decreased visual acuity in 20 percent to 40 percent of eyes that have had cataract surgery. The problem is age-dependent and occurs more frequently in young patients. The rate of PCO among children who have surgery to remove congenital cataracts ranges from 44 percent to 100 percent.
Opacification of the posterior capsule appears to be influenced by lens epithelial cells that are left behind in the eye during cataract removal. The cells multiply, migrate across the posterior lens capsule and undergo changes that cause fibrous or pearl-type opacities in the capsule. The exact mechanism in not completely understood, but it appears to be an aberrant wound healing response to cataract surgery.
Currently, the only treatment for PCO is a type of laser surgery called Nd:YAG laser capsulotomy. In this procedure, a laser is used to create a central opening in the cloudy posterior capsule to restore sight. The procedure is quick and easy, but possible complications of laser capsulotomy include retinal detachment, damage to the intraocular lens (IOC), increase in intraocular pressure and other problems. “Posterior capsular opacification: A problem reduced but not yet eradicated.” Archives of Ophthalmology, April 2009, incorporated by reference herein.
In many clinical studies, the effect of frosting on the lens edge only reduces the glare to a partial ring. That design does not prevent PCO. Further clinical trials indicate that the round edge intraocular lenses do not reduce the amount of PCO experienced by implant patients. The sharp edge design of an intraocular lens indicates reduced PCO formation.
Briefly, in one aspect, the present invention is an improvement to the intraocular lens art. In particular, this invention involves modification of the edge of an ocular device or an annular ring surface or area adjacent to the edge of an ocular device to reduce glare induced by unfiltered light sources. The modification is to apply a coating, layer, polymer, or copolymer of a polarizing component or polarizing element, adjacent to the edge (including upon or on the edge) of an ocular device. A preferred ocular device of this invention is an intraocular lens (IOL). Generally the polarizing component is applied in an annular ring leaving the lens center un-coated.
Applying a polarizing component to the lens periphery or lens edge according to this invention produces better vision by reducing contrast between unfiltered light sources during the day, such as the sun, and shiny objects, such as the surface of a car. Applications of this invention also tends to eliminate or reduce glare induced by e.g., the head lights of oncoming cars or street lights, during the night without decreasing the concentration of light waves that pass through the optic.
It is theorized that development of PCO may also be inhibited or stopped by application of this invention.
The application of a polarizing component as a coating to a lens edge or lens body, according to this invention, will not increase the overall volume of the lens. Nor will this component interfere with the geometry of the lens edges.
It is understood that the present invention involves the application of a polarizing component, generally a light polarizing polymer, adjacent to the edge of an ocular device with the intention of reducing the common forms of glare. The terminology “adjacent to the edge” of an ocular device is intended to include: (a) any actual lens edge, i.e., a surface disposed between the anterior and posterior surface of a lens and being thereby defined by that surface (as opposed to a sharp edge) the edge being a circular band having its center coaxial with the axis of the lens; (b) the annular surface immediately proximate the lens edge on either or both of the anterior or posterior lens surfaces; or (the disjunctive being intentionally chosen) (c), both (a) and (b). This definition means generally that the center of the lens has no polarizing component e.g., a coating thereon.
Specifically, a polarizing component of this invention will cover no more than about 50% of the lens surfaces adjacent the lens edge; preferably no more than about 30% of the lens surface adjacent the lens edge and most preferably no more than about 20% of the lens surface adjacent the lens edge
The following drawings which are a part of the invention serve to explain the properties of the invention.
The present invention utilizes a structured deployment of a polarizing component or coating adjacent to or on the edge of a lens body, (sometimes referred to as the “optic” of a lens) generally without coating any of the lens support structure or fixation means e.g. its haptics. A preferred lens body comprises a optically acceptable polymeric material, the polarizer component comprising poly(vinyl) alcohol (PVA) doped with iodine. PVA-Iodine complexes are extensively discussed in the Miyasaka reference noted below. The polarizer may be a single layer, multiple layers or multiple layers of polarizer having the same axes of polarization. The polarizer may also be a mixture, or a copolymer, preferably doped with I2.
A polymeric lens body or optic of this invention may comprise any optically acceptable polymer to which a polarizer coating of this invention can be permanently bonded. The lens body may be a rigid polymer or preferably a flexible polymeric material e.g., to make a foldable completed lens. Hydrophobic and hydrophilic acrylic materials containing acrylate and methacrylate functionalities are preferred. See, also U.S. Pat. No. 4,916,197 to Vacik et al and. U.S. Pat. No. 5,359,021 to Weinschenk, III.
Miyasaka et al in their review article noted below discuss numerous techniques and methods for formation of polyvinyl alcohol (PVA)/iodine complexes which are the preferred coating material for use in the present invention. At pages 91-96 Miyasaka et al. describe numerous routes for preparation of PVA/iodine complexes each of those preparative routes being specifically incorporated by reference herein. For purposes of this invention generally, and specifically for purposes of PVA/Iodine film polarizers, a PVA film may be first applied to a lens body with polarizer film preparation completed by soaking the PVA film in a solution, e.g., an aqueous solution, of an iodine salt. Further a polarizer film may be directly applied to the lens body from a film solution, e.g., a PVA/Iodine film solution. It is also possible to utilize an iodine/vinyl alcohol monomer solution or mixture which is applied to the lens optic or lens body, the vinyl alcohol monomer then being polymerized to create the polarizer film, in place, e.g., by heating or exposure to UV radiation. Numerous other approaches to aggressively and permanently adhering or bonding a polarizing film to a lens body according to this invention will be suggested to one skilled in this art by the present disclosure.
Polyvinylene-Iodine alone or in combination with PVA is another polarizer coating composition or material to be used in the present invention.
Multiple layers of polarizing components or coatings, including multiple layers of polarizing components of different chemical compositions also are contemplated.
Block copolymers having polarizing characteristics are also contemplated by this invention.
It is noted, in on aspect, that the present invention involves the placement of a polarizing film adjacent to the edge of an ocular device for glare reduction. Numerous techniques are known, and may be used to place, the polarizer film in its intended location on a lens body or optic body. For example dip coating, spin coating, plasma etch and chemical vapor deposition are techniques that could be used. Masking techniques, e.g., masking of the center of the lens body or optic, the mask being removed after placement of the polarizing element or coating to create an uncoated center, is another approach that can be used.
Lenses of this invention, particularly intraocular lenses, comprise a lens body optic with optional supporting haptics. The optic has a central axis, an anterior face, an opposing posterior face and a peripheral edge or edge surface between the anterior and posterior faces. The optic is adapted for placement in the capsular bag of the eye and to direct light toward the retina.
Thus there is shown in
It will be appreciated that the preferred ophthalmic application or device for application of the present invention is an intraocular lens (IOL). One skilled in the IOL art will appreciate that the material selected to produce the IOL must be selected in view of its intended use. For example, the material selected, e.g., for the optic must be optically-acceptable, flexible if, e.g., a foldable lens is chosen, and biocompatible so as not to cause patient immune or other response. “Implantable” would be another characterization of an appropriate optic polymer material.
The following US Patent Documents and Other Publications are specifically incorporated by reference into this application.
The above description and attached figures are intended to be illustrative and not limiting of the above invention which is defined in the following claims.